×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
EBS – emergent biosolutions inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
EBS
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
4/22
06:18 pm
ebs
Emergent (EBS) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
Medium
Report
Emergent (EBS) Q4 2025 Earnings Transcript [Globe and Mail, The (Toronto, Canada)]
4/16
04:05 pm
ebs
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
Low
Report
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
4/16
04:05 pm
ebs
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Low
Report
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
4/9
04:25 pm
ebs
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
Medium
Report
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
4/7
08:05 am
ebs
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Low
Report
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
4/2
08:20 am
ebs
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts [Yahoo! Finance]
Low
Report
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts [Yahoo! Finance]
4/2
08:00 am
ebs
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Low
Report
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
3/25
07:38 pm
ebs
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story [Yahoo! Finance]
Low
Report
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
10/29/2025
04:15 pm
ebs
emergent biosolutions inc.
BEAT
Report
35.2%
emergent biosolutions inc.
8/6/2025
04:15 pm
ebs
emergent biosolutions inc.
BEAT
Report
32.5%
emergent biosolutions inc.
5/7/2025
04:05 pm
ebs
emergent biosolutions inc.
BEAT
Report
34.2%
emergent biosolutions inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
4/22
04:50 pm
ebs
Form DEFA14A Emergent BioSolutions
Medium
Report
Form DEFA14A Emergent BioSolutions
4/17
06:03 am
ebs
Form 8-K Emergent BioSolutions For: Apr 16
Low
Report
Form 8-K Emergent BioSolutions For: Apr 16
4/16
09:33 am
ebs
Form DEFA14A Emergent BioSolutions
Low
Report
Form DEFA14A Emergent BioSolutions
4/16
09:31 am
ebs
Form DEFA14A Emergent BioSolutions
Low
Report
Form DEFA14A Emergent BioSolutions
4/9
01:43 pm
ebs
Form SCHEDULE 13G Emergent BioSolutions Filed by: DIMENSIONAL FUND ADVISORS LP
Low
Report
Form SCHEDULE 13G Emergent BioSolutions Filed by: DIMENSIONAL FUND ADVISORS LP
4/3
04:06 pm
ebs
Form 4 Emergent BioSolutions For: Apr 01 Filed by: Williams Paul Anthony
Low
Report
Form 4 Emergent BioSolutions For: Apr 01 Filed by: Williams Paul Anthony
4/1
04:07 pm
ebs
Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony
Low
Report
Form 144 Emergent BioSolutions Filed by: Williams Paul Anthony
3/26
06:03 pm
ebs
Form SCHEDULE 13G/A Emergent BioSolutions Filed by: VANGUARD GROUP INC
Low
Report
Form SCHEDULE 13G/A Emergent BioSolutions Filed by: VANGUARD GROUP INC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
8/30
Emergent BioSolutions (EBS) Investor Presentation - Slideshow [Seeking Alpha]
14.7%
9/4 Form 8-K Emergent BioSolutions For: Aug 30 10.7%
3/10 Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday [The Motley Fool] 10.2%
3/4 Emergent BioSolutions Selects Axiom Fusion eClinical Suite as Its Global eClinical Suite 9.2%
5/1 Form 8-K/A Emergent BioSolutions For: Apr 30 8.9%
4/23 Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19 8.5%
6/3 Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness 8.2%
4/27 Emergent Biosolutions Inc (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $71.00 price target on the stock. 7.2%
2/27 Form 4 Emergent BioSolutions For: Feb 25 Filed by: Strei Katherine 6.1%
3/11 Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease 5.3%
9/4 Form 8-K Emergent BioSolutions For: Aug 30 10.7%
3/10 Here's Why Emergent Biosolutions, BioMarin, and Nuvasive Fell on Monday [The Motley Fool] 10.2%
3/4 Emergent BioSolutions Selects Axiom Fusion eClinical Suite as Its Global eClinical Suite 9.2%
5/1 Form 8-K/A Emergent BioSolutions For: Apr 30 8.9%
4/23 Emergent BioSolutions Signs Agreement to be U.S. Manufacturing Partner for Johnson & Johnson’s Lead Vaccine Candidate for COVID-19 8.5%
6/3 Emergent BioSolutions Awarded 10-Year HHS Contract Valued at Approximately $535 Million to Deliver Vaccinia Immune Globulin Intravenous (VIGIV) in Support of Smallpox Preparedness 8.2%
4/27 Emergent Biosolutions Inc (NYSE: EBS) had its "buy" rating re-affirmed by analysts at Chardan Capital. They now have a $71.00 price target on the stock. 7.2%
2/27 Form 4 Emergent BioSolutions For: Feb 25 Filed by: Strei Katherine 6.1%
3/11 Emergent BioSolutions Initiates Development of Plasma-Derived Product Candidates for the Treatment and Prevention of Coronavirus Disease 5.3%
TOP News Decliners
3/13
Why These Drug Stocks Soared Today [The Motley Fool]
-15.6%
3/6 Form 3/A Emergent BioSolutions For: Mar 05 Filed by: Kirk Sean -10.5%
11/7 Emergent Biosolutions Inc (NYSE: EBS) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $67.00 price target on the stock. -10.0%
3/10 Here's Why Emergent BioSolutions Jumped Higher on Tuesday [The Motley Fool] -9.3%
3/31 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ -6.1%
4/20 Form 4 Emergent BioSolutions For: Apr 16 Filed by: El-Hibri Fuad -5.7%
10/21 Emergent BioSolutions to Host 2019 Analyst & Investor Day -5.2%
9/10 Form 4 Emergent BioSolutions For: Sep 09 Filed by: Zoon Kathryn C -4.9%
3/2 Form 4 Emergent BioSolutions For: Feb 27 Filed by: Bailey Sue -4.6%
10/7 Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September [The Motley Fool] -4.2%
3/6 Form 3/A Emergent BioSolutions For: Mar 05 Filed by: Kirk Sean -10.5%
11/7 Emergent Biosolutions Inc (NYSE: EBS) had its "hold" rating re-affirmed by analysts at Cowen Inc. They now have a $67.00 price target on the stock. -10.0%
3/10 Here's Why Emergent BioSolutions Jumped Higher on Tuesday [The Motley Fool] -9.3%
3/31 Emergent BioSolutions Signs Agreement with Novavax to Manufacture NanoFlu™ -6.1%
4/20 Form 4 Emergent BioSolutions For: Apr 16 Filed by: El-Hibri Fuad -5.7%
10/21 Emergent BioSolutions to Host 2019 Analyst & Investor Day -5.2%
9/10 Form 4 Emergent BioSolutions For: Sep 09 Filed by: Zoon Kathryn C -4.9%
3/2 Form 4 Emergent BioSolutions For: Feb 27 Filed by: Bailey Sue -4.6%
10/7 Here’s Why Emergent BioSolutions Stock Climbed 19.4% in September [The Motley Fool] -4.2%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: